A trio of med-tech titans logged a win against Johnson & Johnson (NYSE:JNJ) in a long-running battle over drug-eluting coronary stent patents.
Patent Infringement
Bard sues AngioDynamics, Smiths Medical over access port patents | Legal News
MassDevice.com +3 | MassDevice Q&A with Medtronic CEO Omar Ishrak, Judge strikes down Conceptus’ injuction against Hologic and CMS blames economy for health care spending drop
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Judge strikes down Conceptus’ request for an injunction against Hologic
MassDevice.com +3 | Philips takes another shot at Zoll over patents, Discredited vaccine-autism doc sues critics and fewer mergers but higher pricetags in 2011
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Philips takes another shot at Zoll over AED patents | Legal Roundup
Philips Healthcare (NYSE:PHG) plans to go another round with Zoll Medical Corp. (NSDQ:ZOLL) over automated external defibrillators, suing Zoll in Washington state over a new string of allegedly infringed patents.
Philips wants a jury to issue an injunction to keep Zoll from selling its AED Plus and AED Pro devices, as well as compensation for lost sales and legal fees.
Philips takes another shot at Zoll over AED patents
Philips Healthcare (NYSE:PHG) plans to go another round with Zoll Medical Corp. (NSDQ:ZOLL) over automated external defibrillators, suing Zoll in Washington state over a new string of allegedly infringed patents.
Philips wants a jury to issue an injunction to keep Zoll from selling its AED Plus and AED Pro devices, as well as compensation for lost sales and legal fees.
MassDevice.com +3 | SNN spins out biologics unit, Varian’s RPM infringes Pitt patent and Cook chairman decries “tongue-depressor tax”
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Judge: Varian’s RPM infringes Pitt patent
A federal jury in Pennsylvania is slated to decide whether Varian Medical Systems’ (NYSE:VAR) infringement of a University of Pittsburgh patent was willful later this month, after a judge there ruled that the RPM respiratory gating system violates one of the school’s patents.
MassDevice.com +7 | Meelia says goodbye, SNN’s overturned patent win, Covidien’s Nellcor, FDA to BSX: shrinkage, MD’s overstenting doc, IRS to MDT: pay up, Chinese price controls
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this holiday weekend, make sure you’re still in the know with MassDevice +7 and Happy Holidays from everyone at MassDevice!
Judge overturns Smith & Nephew’s $85M patent win over Arthrex
Smith & Nephew (NYSE:SNN) saw its $85 million patent win against Arthrex Inc. overturned this week, after an Oregon judge ruled that Arthrex didn’t infringe on SNN’s surgical anchor patents.
The latest round in the 7-year-old patent lawsuit found that "no reasonable jury could possibly find that Arthrex infringed in this case," including via indirect infringement.